Atlas Trials

A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients

Clinical trial NCT00002195 · COMPLETED

Trial details

NCT number
NCT00002195
Sponsor
Glaxo Wellcome
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HIV Infections
Enrollment
290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.